S7 Clinical Research Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 6.30 M
About S7 Clinical Research
S7 Clinical Research Private Limited (SCRPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 March 2011 and has a history of 13 years and 11 months. Its registered office is in Nashik, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹6.30 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Shailesh Bondarde and Nutan Bondarde serve as directors at the Company.
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85100MH2011PTC214521
- Company No.
214521
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Mar 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at S7 Clinical Research?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shailesh Bondarde  | Director | 09-Mar-2011 | Current |
| Nutan Bondarde | Director | 09-Mar-2011 | Current |
Financial Performance of S7 Clinical Research.
S7 Clinical Research Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of S7 Clinical Research?
In 2017, S7 Clinical Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Apex Wellness Hospital LlpShailesh Bondarde is a mutual person
- Apex Wellness Pharma Llp
Shailesh Bondarde is a mutual person
- Sahyadri Seva Health Care Private Limited
Shailesh Bondarde is a mutual person
- Nog Healthcare Private Limited
Shailesh Bondarde is a mutual person
Charges (Loans)
₹0
₹6.30 M
Charges Breakdown by Lending Institutions
- Others : 0.63 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Jan 2017 | Others | ₹6.30 M | Satisfied |
How Many Employees Work at S7 Clinical Research?
Unlock and access historical data on people associated with S7 Clinical Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of S7 Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped S7 Clinical Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.